VARGATEF < sup > ® < /sup > plus docetaxel significantly reduced tumour burden in lung cancer patients with advanced adenocarcinoma compared to docetaxel alone

VARGATEF < sup > ® < /sup > plus docetaxel significantly reduced tumour burden in lung cancer patients with advanced adenocarcinoma compared to docetaxel alone
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news